Drug profile · INN
nicardipine hydrochloride
NICARDIPINE HYDROCHLORIDE
nicardipine hydrochloride (NICARDIPINE HYDROCHLORIDE) is a voltage-gated l-type calcium channel blocker. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
Drug details — nicardipine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
nicardipine hydrochloride (NICARDIPINE HYDROCHLORIDE) is a voltage-gated l-type calcium channel blocker. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nicardipine hydrochloride?
nicardipine hydrochloride (NICARDIPINE HYDROCHLORIDE) is a voltage-gated l-type calcium channel blocker. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nicardipine hydrochloride?
NICARDIPINE HYDROCHLORIDE is a marketed brand name for nicardipine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nicardipine hydrochloride?
nicardipine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.